Search

for
Search:

GlossaryMelphalan

chemotherapy drug that interferes with DNA in cancer cells

Melphalan, also known as Alkeran, is a chemotherapy drug used to treat certain types of cancer, such as multiple myeloma and ovarian cancer. It works by interfering with the DNA in cancer cells, preventing them from growing and dividing.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 102 results

research Pityriasis Amiantacea Following Bone Marrow Transplant

1 citations , January 2019 in “PubMed”

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

research Alopecia and Hair Damage Induced by Oncological Therapy

7 citations , October 2019 in “Klinická onkologie”

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

research Scalp Biopsy Identifies Systemic Amyloidosis Presenting as Isolated Telogen Effluvium: A Case Report

January 2019 in “SAGE Open Medical Case Reports”

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

research Categorization of Long-Lasting Hair Changes in Patients After Hematopoietic Stem Cell Transplants

August 2018 in “Journal of the American Academy of Dermatology”

Patients often experience long-lasting changes to their hair after stem cell transplants.

Rapid Full Engraftment and Successful Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning in Omenn Syndrome

research Rapid Full Engraftment and Successful Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning in Omenn Syndrome

8 citations , August 2009 in “Pediatric transplantation”

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

View more "melphalan" in research →

Community Join

0 / 0 results

— no results